.Pharmacolibrary.Drugs.ATC.C.C02CA01 .Pharmacolibrary.Drugs.ATC.C.C02CA01| name: | Prazosin |
| ATC code: | C02CA01 | route: | oral |
| n-compartments | 2 |
Prazosin is an alpha-1 adrenergic receptor antagonist primarily used for the treatment of hypertension and symptoms of benign prostatic hyperplasia. It is also used off-label in the management of post-traumatic stress disorder (PTSD)-associated nightmares in adults. Prazosin is an approved and commonly used medication today.
Pharmacokinetic parameters reported in healthy adult male subjects after oral administration.
Kwon, YH, et al., & Chun, IK (2007). Pharmacokinetics of doxazosin gastrointestinal therapeutic system after multiple administration in Korean healthy volunteers. Drug development and industrial pharmacy 33(8) 824–829. DOI:10.1080/03639040601012999 PUBMED:https://pubmed.ncbi.nlm.nih.gov/17729099
Liu, M, et al., & Liu, H (2012). Pharmacokinetics of terazosin enantiomers in healthy Chinese male subjects. Chirality 24(12) 1047–1050. DOI:10.1002/chir.22095 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22887707
Yan, M, et al., & Zhu, YG (2010). Determination of metoclopramide in human plasma by LC-ESI-MS and its application to bioequivalance studies. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 878(11-12) 883–887. DOI:10.1016/j.jchromb.2010.02.006 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20189472